DXC Technology Co (DXC): what the price assumes

boothcheck covers DXC Technology Co (DXC) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-25.

Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/DXC

Headline

FieldValue
TickerDXC
CompanyDXC Technology Co
Sector / IndustryTechnology
Current price$11.66/sh
CompositionCES (Consulting and Engineering Services) 40% / GIS (Global Infrastructure Services) 50% / Insurance (Insurance Software & Services) 10%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)2.5%
Operating margin today7.2%
Margin compression (value-band)-4.7pp
Multiple paid10x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 3.5% sits below it).

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.31σ
cohort percentile (of 190 peers)5

Valuation X-Ray

The price is supported by earnings-power value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.39x5expensive
Earnings0.17x3justifies
Relative0
Growth0

Families that justify the price: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 3.6%); the inversion above states its own rate.

Per-Model Detail (n=8)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$214.910.05xnoFCF base $1.3B, growth -2% (input: historical growth), terminal g 0.5%, WACC 3.6%, 5yr projection
DCF Exit MultipleGrowth$46.390.25xnoExit EV/EBITDA: 4.0x / 1.7x / 3.7x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelativenoP/E 27.01x (blended: static sector reference 35x + trailing (TTM) 15x), scenarios: 23.0x / 27.0x / 31.1x (bear / base = reference held flat / bull), EV/EBITDA 15.7x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$8.391.39xyesBV/sh $19.13, ROE (TTM) 4.1%, ke 9.3%
Two-Stage Excess ReturnAsset$5.372.17xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$6.851.70xnoRev $12.5B, growth -2% (input: historical growth; tapered), Terminal P/S: 0.1x / 0.1x / 0.2x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$8.881.31xnoEPS $0.74, growth 2% (input: historical EPS growth), PEG=9.41 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$119.280.10xnoNormalized EBIT (5y avg op income, one-time charges added back) $1.26B × (1−40%) / WACC 3.6% → EPV (no growth)
Residual IncomeAsset$4.332.69xyesBV $19.13 + 5yr PV of (ROE (TTM) 4.1% − Kₑ 9.3%) × BV; BV grows 2.6%/yr
Graham NumberAsset$17.850.65xyes√(22.5 × EPS $0.74 × BVPS $19.13) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $2.05B × sector EV/EBITDA 25.0x
FCF YieldEarnings$73.970.16xyesFCF $1252.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$68.490.17xyesSBC-adj FCF $1.17B (FCF $1.25B − SBC $0.08B) capitalized at Kₑ
Ben Graham FormulaEarnings$23.880.49xyesEPS $0.74 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$9.931.17xyesBV $19.13 × (ROIC 1.9% / WACC 3.6%)
P/Sales SectorRelativenoRevenue $12.48B × sector P/S 8.0x
PEG Fair ValueRelative$27.750.42xnoEPS $0.74 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$8.001.46xnoEPS $0.74 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
CESoperatingenterprise$5.0b$518.0m operating-incomewithheldunresolved no unit value
GISoperatingenterprise$6.3b$432.0m operating-incomewithheldunresolved no unit value
Insuranceoperatingenterprise$1.3b$129.0m operating-incomewithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$820.0m
Net debt / NOPAT (after-tax)1.74x
Net debt / operating income (pre-tax)0.91x
Interest coverage4.2x
Share count CAGR (buyback)-8.5%
Burning cashno

Bullet Takeaways

Bull Case

The clearest statement management has made about where it sees value is not in any press release. It is in the share count, which has fallen roughly 8.9% a year over the four years to the end of 2025. Compound that and close to a third of the company has been retired. For a business this size, that is an enormous amount of stock taken off the market by a board that could have spent the same money on acquisitions and chose not to.

Reported profit is the wrong place to look for what funded it. Operating profit ran about 1.02 billion dollars on 12.6 billion dollars of revenue, roughly an 8% operating margin, while the fiscal 2026 bottom line came in at 18 million dollars. That collapse did not happen in operations. The 10-K points to "the unfavorable summary judgment in a tax matter relating to a foreign exchange tax case" in fiscal 2026, and the same filing notes that "Impairment losses are included within Other expense (income), net on the statements of operations". Two lines that describe the same year can therefore look like two different companies, and the cash statement sides with the higher one.

The capital structure is boring in the useful sense. At March 31, 2026 the long-term debt carrying amount stood at 3.6 billion dollars, "of which none was floating interest rate debt", alongside 520 million dollars of short-term borrowings and current maturities. The company is also unwinding the equipment financings that used to sit alongside that: payments on capital leases and borrowings for asset financings dropped by 110 million dollars as "the Company continues reducing the volume of these financing arrangements". Fixed coupons and a shrinking financing tail are the configuration that buys time.

The smallest of the three businesses is the one that least resembles the rest. Insurance software and services is about a tenth of revenue and competes against a cohort that earns real software economics: VRSK runs a 44.0% operating margin, and SSNC turns 23.1% on revenue of 6.41 billion dollars while growing 7.5%. DXC's July announcement that it had finished a cloud conversion for Wilton Re, which it called one of the largest transformation programs in its history, is evidence that this piece still wins the kind of work that takes years to displace.

None of that requires optimism to be worth something. The methods that capitalize cash flow, and the earnings-power lens, land far above today's price rather than struggling to reach it. More concretely, the price does not need the current margin to hold. It is consistent with operating margins settling near 2.6% against roughly 8% earned on a trailing basis. A buyer here is not paying for a turnaround. They are paying for the decline to be merely bad.

Bear Case

Accenture pulled all of its services into a single integrated organization effective September 1, 2025. Cognizant tells its own investors that clients "are confronted with the risk of being disrupted by nimble, AI-native competitors" and is reorganizing around that. Both of them are growing while DXC is not: ACN turned a 14.5% operating margin on 73.1 billion dollars of revenue growing 6.7%, and CTSH a 15.8% margin on 21.4 billion dollars growing 6.5%. DXC's organic revenue fell 4.8% in fiscal 2026. Growth is the axis this comparison turns on, and on that axis the gap is not narrow.

The balance sheet makes the same point from the other side. Book value per share is 16.73 dollars and the shares change hands at 10.05. Trading below book usually reads as a bargain, and here it is not, because the return that book produces is close to nothing. Part of that is the tax judgment, and stripping it out improves the arithmetic. It does not change the shape of it: capital earning less than what it costs to hold destroys a little value every year it stays employed, and the market prices books accordingly. Nine years after the 2017 merger of CSC and HPES that created the company, the equity statement still carries an accumulated deficit rather than retained earnings.

Automation runs the wrong direction for the largest segment. Managed infrastructure is billed by seat, by device, by incident. When the labour required to deliver it halves, the client's next renewal asks for the saving rather than granting it, and the vendor with the newest delivery model sets that price. The category's economics are visible in the closest structural comparison available: KD, spun out of IBM to do essentially this work at scale, earns a 1.3% profit margin on 15.1 billion dollars of revenue with growth of 0.2%. Running critical systems for large enterprises is necessary work. It has not lately been lucrative work.

Which brings the argument to what the price already concedes. This is not an overvaluation case; the shares sit below what even a 5% a year decline in operating profit would warrant, so the market has already marked the business down hard. The bear case is that a 5% decline is a floor rather than a worst case. Organic revenue is already falling faster than that, half the revenue base is the part clients are most actively trying to automate away, and goodwill has been written down to 526 million dollars with a further 14 million dollar impairment taken in the first quarter of fiscal 2026. A cheap price protects a holder against disappointment. It does not protect against a business that keeps getting smaller.

Valuation

Today's price does not ask this business to grow. It sits below what even a 5% a year decline in operating profit would warrant, which is an unusual thing to be able to say about a company earning roughly an 8% operating margin on 12.6 billion dollars of revenue. The starting question is therefore not whether the shares are cheap against the fundamentals but how fast those fundamentals are allowed to shrink before cheap stops meaning anything.

The methods split violently here, and the split is the analysis. The approaches that capitalize cash flow, the earnings-power family and the peer-multiple family all land far above where the shares trade. The asset-and-returns family lands below the price, which is why that family reads as the expensive one. Both readings describe the same company. One is watching cash arrive; the other is watching a large book of capital produce almost no return on its way past. The distance between those two views is the whole DXC argument, and no single number reconciles them.

One caution belongs on the peer read. The comparison set spans consultancies, enterprise software vendors and infrastructure operators whose economics differ by an order of magnitude: VRSK earns a 44.0% operating margin while KD earns a 1.3% profit margin. Applying one sector reference across a spread that wide produces a number, not an insight, which makes that family the least decisive of the four in this case.

Turn the priced-in assumption around and it reads more concretely. Rather than requiring margin expansion, today's price is consistent with operating margins settling near 2.6% against roughly 8% on a trailing basis, or keeping about a third as much of each revenue dollar as the business keeps now. That is the shape of the bet: not recovery, and not even stability, but a decline that stops somewhere short of the one the price allows for.

Solvency sets the boundary on how much time that argument gets. At March 31, 2026 the long-term debt carrying amount was 3.6 billion dollars with none of it floating rate, plus 520 million dollars of short-term borrowings and current maturities, and the equipment financings that sit alongside are being run down. Fixed coupons on a business still producing an operating profit measured in the high hundreds of millions is a survivable structure. What it does not do is make the revenue line stop falling, and the revenue line is what the whole case turns on.

Catalysts

Fiscal first-quarter results are due July 30, 2026. It is the first print after a fiscal year that closed on June 11 with revenue of $12.64 billion and net income of 18 million dollars, the latter down sharply on the prior year. The line to watch is organic revenue rather than the headline, since currency has been flattering the comparison.

Two June events matter more than a typical quarter's news. On June 11 the company announced a multi-year global alliance with Anthropic to embed AI into mission-critical enterprise systems. On June 23 it collected 213.56 million dollars from Tata Consultancy Services in settlement of an intellectual property dispute. Against a market value under 2 billion dollars, the settlement is a material one-off receipt. The alliance is the more consequential of the two, because it decides whether AI reaches the income statement as a lower delivery cost or as a discount clients insist on at renewal.

Two smaller markers round out the month. On July 8 the company said it had completed a cloud conversion for Wilton Re, calling it one of the largest transformation programs in its history, and the same day TD Cowen trimmed its target and kept a Hold rating. The annual meeting on July 20 covered fiscal 2026 performance and the AI strategy. None of these move the revenue trajectory by themselves; the July 30 print is where that trajectory shows up.

Peer Cohorts (Per Segment, With Filing Citations)

CES (reported)

GIS (reported)

Insurance (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

DXC and Anthropic joint announcement, June 11, 2026 · DXC announcement, July 8, 2026 · DXC earnings date listing, stockanalysis.com, July 2026 · DXC fiscal 2026 results, reported June 11, 2026 · reported settlement collection, June 23, 2026 · TD Cowen research note, July 8, 2026 · DXC AGM 2026 transcript, July 20, 2026

View the full interactive DXC report on boothcheck